The Impact Of First-Line Tyrosine Kinase Inhibitors (Tkis) On Overall Survival In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) And Activating Epidermal Growth Factor Receptor (Egfr) Mutations- Meta-Analysis Of Major Randomized ...
Abstract
Authors
T Kato F De Marinis J Spicer M Sebastian I Griebsch A Märten J Lungershausen R Shah